file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 801 | FATE | 6 | 7 | 29 |
| 802 | HLA-DRB1 | 10 | 7 | 10 |
| 803 | IMPLANTATION | 3 | 7 | 18 |
| 804 | KAPOSI | 1 | 7 | 95 |
| 805 | LIGAND | 4 | 7 | 104 |
| 806 | LYMPHATIC | 1 | 7 | 67 |
| 807 | MAINLY | 1 | 7 | 8 |
| 808 | MATTER | 2 | 7 | 45 |
| 809 | MONITORING | 4 | 7 | 56 |
| 810 | OBLITERATIVE | 1 | 7 | 67 |
| 811 | ORIGINATES | 1 | 7 | 95 |
| 812 | PERV | 9 | 7 | 101 |
| 813 | PLACENTAL | 2 | 7 | 14 |
| 814 | PORTAL | 3 | 7 | 15 |
| 815 | POST-TRANSPLANT | 1 | 7 | 95 |
| 816 | PREDICTS | 4 | 7 | 12 |
| 817 | PREGNANCY-ASSOCIATED | 4 | 7 | 16 |
| 818 | PRIMATES | 5 | 7 | 32 |
| 819 | PROTECTION | 2 | 7 | 15 |
| 820 | PROVIDE | 1 | 7 | 10 |
| 821 | REGULARLY | 1 | 7 | 29 |
| 822 | REGULATION | 4 | 7 | 14 |
| 823 | RESTORATION | 1 | 7 | 37 |
| 824 | SARCOMA | 2 | 7 | 100 |
| 825 | SEEDING | 1 | 7 | 95 |
| 826 | SELF-RECOGNITION | 1 | 7 | 14 |
| 827 | SPLEEN-DERIVED | 1 | 7 | 37 |
| 828 | STILL | 2 | 7 | 7 |
| 829 | TRANSPLANTED | 9 | 7 | 99 |
| 830 | TUBULAR | 1 | 7 | 29 |
| # | Word | Recs | TLCS | TGCS |
| 831 | TWELVE | 1 | 7 | 74 |
| 832 | URINARY | 1 | 7 | 34 |
| 833 | VACCINE-LIKE | 1 | 7 | 10 |
| 834 | XENOGENEIC | 6 | 7 | 19 |
| 835 | ANTIDONOR | 1 | 6 | 36 |
| 836 | APPENDIX | 2 | 6 | 7 |
| 837 | BENEFICIAL | 2 | 6 | 8 |
| 838 | CANINE | 9 | 6 | 59 |
| 839 | CARCINOGENESIS | 2 | 6 | 6 |
| 840 | EMPHASIS | 1 | 6 | 22 |
| 841 | ENGRAFTED | 2 | 6 | 6 |
| 842 | FLOW | 5 | 6 | 15 |
| 843 | FLT3 | 5 | 6 | 40 |
| 844 | FOETAL | 4 | 6 | 25 |
| 845 | FRENCH | 4 | 6 | 8 |
| 846 | GRAVID | 1 | 6 | 22 |
| 847 | GROWTH | 3 | 6 | 35 |
| 848 | HUMANS | 3 | 6 | 16 |
| 849 | IMMATURE | 5 | 6 | 103 |
| 850 | IMMUNOSUPPRESSANTS | 1 | 6 | 54 |
| 851 | INFLAMMATION | 3 | 6 | 9 |
| 852 | INFUSED | 1 | 6 | 36 |
| 853 | INTERACTIONS | 3 | 6 | 22 |
| 854 | LASTING | 1 | 6 | 7 |
| 855 | LEAD | 2 | 6 | 19 |
| 856 | MACROCHIMERISM | 2 | 6 | 15 |
| 857 | MATCHED | 3 | 6 | 24 |
| 858 | MESENCHYMAL | 7 | 6 | 178 |
| 859 | MICROCHIMAERISM | 2 | 6 | 16 |
| 860 | MODULATION | 4 | 6 | 35 |
| # | Word | Recs | TLCS | TGCS |
| 861 | PHASE | 3 | 6 | 177 |
| 862 | PLUS | 2 | 6 | 54 |
| 863 | POTENT | 2 | 6 | 44 |
| 864 | PROTOCOLS | 1 | 6 | 18 |
| 865 | RAPID | 4 | 6 | 43 |
| 866 | RECRUITS | 2 | 6 | 28 |
| 867 | REGULATORS | 1 | 6 | 36 |
| 868 | SCLERODEMA | 1 | 6 | 8 |
| 869 | SIGNIFICANCE | 2 | 6 | 21 |
| 870 | SUBSET | 2 | 6 | 8 |
| 871 | THREE | 2 | 6 | 8 |
| 872 | TOLERANCE-INDUCING | 1 | 6 | 18 |
| 873 | TRAFFIC | 5 | 6 | 38 |
| 874 | UNFINISHED | 1 | 6 | 22 |
| 875 | UNMANIPULATED | 5 | 6 | 24 |
| 876 | VULVAR | 3 | 6 | 7 |
| 877 | 2-LOCI-MISMATCHED | 2 | 5 | 16 |
| 878 | ALPHA-THALASSEMIA-1 | 1 | 5 | 34 |
| 879 | ANEMIA | 4 | 5 | 94 |
| 880 | ANTI-CD3-IMMUNOTOXIN | 1 | 5 | 93 |
| 881 | ANTI-CD40L | 3 | 5 | 62 |
| 882 | ANTIBODIES | 11 | 5 | 116 |
| 883 | APPLICATION | 3 | 5 | 10 |
| 884 | AUGMENTED | 2 | 5 | 47 |
| 885 | AUTREVE | 2 | 5 | 10 |
| 886 | AUWERA | 2 | 5 | 10 |
| 887 | BADENHOOP | 2 | 5 | 10 |
| 888 | BEARING | 3 | 5 | 6 |
| 889 | BOVINE | 2 | 5 | 71 |
| 890 | CASE | 10 | 5 | 57 |
| # | Word | Recs | TLCS | TGCS |
| 891 | CHANGES | 4 | 5 | 23 |
| 892 | CHANGING | 1 | 5 | 25 |
| 893 | COMBINING | 4 | 5 | 38 |
| 894 | COMORBIDITIES | 1 | 5 | 130 |
| 895 | COMPLETE | 3 | 5 | 52 |
| 896 | CONTROLLED | 1 | 5 | 130 |
| 897 | CORRELATE | 3 | 5 | 18 |
| 898 | CYTOKINE-STIMULATED | 2 | 5 | 14 |
| 899 | CYTOMETRY | 2 | 5 | 9 |
| 900 | DENMARK | 2 | 5 | 9 |
| 901 | DIABETOLOGIA | 2 | 5 | 10 |
| 902 | DONOR-STRAIN | 1 | 5 | 66 |
| 903 | EPITHELIAL | 4 | 5 | 56 |
| 904 | ESTABLISHED | 2 | 5 | 10 |
| 905 | GENE | 7 | 5 | 59 |
| 906 | GORUS | 2 | 5 | 10 |
| 907 | GREEN | 3 | 5 | 99 |
| 908 | HAMSTER-TO-RAT | 6 | 5 | 13 |
| 909 | HYBRIDISATION | 2 | 5 | 21 |
| 910 | HYPOTHESES | 1 | 5 | 7 |
| 911 | HYPOTHESIS | 2 | 5 | 25 |
| 912 | IMMUNOSUPPRESSED | 3 | 5 | 42 |
| 913 | INFUSIONS | 3 | 5 | 44 |
| 914 | INSIGHTS | 5 | 5 | 74 |
| 915 | INTERVIEW-BASED | 1 | 5 | 130 |
| 916 | METHODOLOGY | 1 | 5 | 8 |
| 917 | OPERATIONAL | 2 | 5 | 93 |
| 918 | ORAL | 2 | 5 | 7 |
| 919 | PANI | 2 | 5 | 10 |
| 920 | PARTNERS | 2 | 5 | 8 |
| # | Word | Recs | TLCS | TGCS |
| 921 | PERITRANSPLANT | 1 | 5 | 93 |
| 922 | PHENOMENON | 2 | 5 | 74 |
| 923 | PLAY | 4 | 5 | 12 |
| 924 | PRECLINICAL | 1 | 5 | 93 |
| 925 | PREREQUISITE | 2 | 5 | 17 |
| 926 | PREVENTION | 6 | 5 | 107 |
| 927 | PROTEIN | 2 | 5 | 9 |
| 928 | RECIPIENT-DONOR | 1 | 5 | 8 |
| 929 | RECURRENT | 3 | 5 | 13 |
| 930 | RED | 6 | 5 | 45 |
| 931 | REMISSION | 1 | 5 | 35 |
| 932 | RETRACTED | 2 | 5 | 75 |
| 933 | SEE | 2 | 5 | 75 |
| 934 | SELF | 2 | 5 | 25 |
| 935 | SPECIAL | 1 | 5 | 46 |
| 936 | STRAINS | 1 | 5 | 9 |
| 937 | SUSCEPTIBILITY | 3 | 5 | 21 |
| 938 | THYMUS | 7 | 5 | 14 |
| 939 | TRANSGENIC | 4 | 5 | 26 |
| 940 | UNMODIFIED | 3 | 5 | 35 |
| 941 | UNRELATED | 5 | 5 | 15 |
| 942 | VAN | 2 | 5 | 10 |
| 943 | ADOLESCENTS | 2 | 4 | 15 |
| 944 | ALLELIC | 2 | 4 | 33 |
| 945 | ALLOPEPTIDES | 1 | 4 | 28 |
| 946 | APLASTIC | 1 | 4 | 8 |
| 947 | APOPTOSIS | 1 | 4 | 45 |
| 948 | AUGMENTATION | 4 | 4 | 16 |
| 949 | AUGMENTS | 2 | 4 | 5 |
| 950 | BETWIXT | 1 | 4 | 27 |
| # | Word | Recs | TLCS | TGCS |
| 951 | BLOCKING | 2 | 4 | 9 |
| 952 | BREASTFEEDING-INDUCED | 1 | 4 | 12 |
| 953 | BRIEF | 1 | 4 | 56 |
| 954 | CANCERS | 2 | 4 | 31 |
| 955 | CHANGE | 1 | 4 | 4 |
| 956 | COHORT | 4 | 4 | 26 |
| 957 | CONCEPT | 1 | 4 | 19 |
| 958 | CYTOABLATION | 1 | 4 | 26 |
| 959 | CYTOKINE | 2 | 4 | 10 |
| 960 | DECADES | 5 | 4 | 171 |
| 961 | DECEASED | 2 | 4 | 15 |
| 962 | DECEASED-DONOR | 1 | 4 | 56 |
| 963 | DEGREE | 4 | 4 | 5 |
| 964 | DETECT | 9 | 4 | 19 |
| 965 | DETERMINATION | 7 | 4 | 16 |
| 966 | DEVELOPS | 1 | 4 | 7 |
| 967 | DIABETIC | 3 | 4 | 17 |
| 968 | DIFFICULTY | 1 | 4 | 5 |
| 969 | ELIMINATING | 1 | 4 | 5 |
| 970 | EXISTENCE | 2 | 4 | 4 |
| 971 | FACILITATE | 4 | 4 | 36 |
| 972 | FAMILIAL | 2 | 4 | 9 |
| 973 | FATAL | 1 | 4 | 10 |
| 974 | FETAL-CELL | 1 | 4 | 6 |
| 975 | FETUS-DERIVED | 1 | 4 | 7 |
| 976 | FORENSIC | 2 | 4 | 5 |
| 977 | GENERAL | 1 | 4 | 10 |
| 978 | GENOMIC | 1 | 4 | 82 |
| 979 | HAEMATOLOGICAL | 1 | 4 | 10 |
| 980 | HAPLOTYPE | 3 | 4 | 14 |
| # | Word | Recs | TLCS | TGCS |
| 981 | HEART-TRANSPLANTED | 1 | 4 | 4 |
| 982 | HEAVILY | 1 | 4 | 8 |
| 983 | HELPER | 2 | 4 | 11 |
| 984 | HIGHER | 4 | 4 | 86 |
| 985 | HLA-IDENTICAL | 3 | 4 | 26 |
| 986 | IMMUNOREACTIVE | 1 | 4 | 45 |
| 987 | INDEFINITE | 1 | 4 | 26 |
| 988 | INFANTILE | 3 | 4 | 23 |
| 989 | INHIBITION | 2 | 4 | 45 |
| 990 | INTEGRINS | 1 | 4 | 15 |
| 991 | INTERMEDIATE-TERM | 1 | 4 | 21 |
| 992 | INVESTIGATION | 2 | 4 | 18 |
| 993 | INVOLVES | 1 | 4 | 15 |
| 994 | LENGTH | 3 | 4 | 16 |
| 995 | LIMB | 8 | 4 | 36 |
| 996 | LYMPHOPOIESIS | 1 | 4 | 6 |
| 997 | MAB | 1 | 4 | 45 |
| 998 | MARROW-AUGMENTED | 1 | 4 | 22 |
| 999 | MOLECULE | 3 | 4 | 58 |
| 1000 | NON-HUMAN | 3 | 4 | 26 |